REFERENCES
- Litovitz T.L., Klein-Schwartz W., White S., Cobaugh D.J., Youniss J., Drab A., Benson B.E. 1999 Annual Report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am. J. Emerg. Med. 2000; 18(5)517–574
- Kalkan S., Tuncok Y., Guven H. Poisonings Reported to Drug and Poison Information Center, in Izmir. J. Dokuz Eylul Univ. School Med. 1998; 12(3)275–283, in Turkish
- Pimentel L., Trommer L. Cyclic Antidepressant Overdoses. Emerg. Med. Clin. N. Am. 1994; 12(2)533–547
- Shannon M., Liebelt E.L. Toxicology Reviews: Targeted Management Strategies for Cardiovascular Toxicity from Tricyclic Antidepressant Overdose: The Pivotal Role for Alkalinization and Sodium Loading. Pediatr. Emerg. Care 1998; 14(4)293–298
- Moncada S., Palmer R.M.J., Higgs E.A. Nitric Oxide: Physiology, Pathophysiology and Pharmacology. Pharmacol. Rev. 1991; 43: 109–142
- Lowenstein C.J., Dinerman J.L., Snyder S.H. Nitric Oxide: A Physiologic Messenger. Ann. Intern. Med. 1994; 120: 227–237
- Kilbourn R.G., Gross S.S., Jubran A., Adams J., Griffith O.W., Levi R., Lodato R.F. NG-Methyl-l-Arginine Inhibits Tumor Necrosis Factor-Induced Hypotension: Implications for the Involvement of Nitric Oxide. Proc. Natl Acad. Sci. USA 1990; 87: 3629–3632
- Kilbourn R.G., Jubran A., Gross S.S., Griffith O.W., Levi R., Adams J., Lodato R.F. Reversal of Endotoxin-Mediated Shock by NG-methyl-l-arginine, an Inhibitor of Nitric Oxide Synthesis. Biochem. Biophys. Res. Commun. 1990; 172: 1132–1138
- Petros A., Bennet D., Vallance P. Effect of Nitric Oxide Synthase Inhibitors on Hypotension in Patients with Septic Shock. Lancet 1991; 338: 1557–1558
- Pentel P.R., Wananukul W., Scarlett W., Keyler D.E. Nitric Oxide Contributes to Desipramine-Induced Hypotension in Rats. Hum. Exp. Toxicol. 1996; 15: 320–328
- Nurminen M.L., Vapaatalo H. Effect of Intracerebroventricular and Intravenous Administration of Nitric Oxide Donors on Blood Pressure and Heart Rate in Anaesthetized Rats. Br. J. Pharmacol. 1996; 119(7)1422–1426
- Fouyas I.P., Kelly P.A.T., Ritchie I.M., Whittle I.R. Cerebrovascular Effects of Nitric Oxide Manipulation in Spontaneously Hypertensive Rats. Br. J. Pharmacol. 1997; 121: 49–56
- Pfeiffer S., Leopold E., Schmidt K., Brunner F., Mayer B. Inhibition of Nitric Oxide Synthesis by NG-Nitro-l-Arginine Methyl Ester (l-NAME): Requirement for Bioactivation to the Free Acid, NG-Nitro-l-Arginine. Br. J. Pharmacol. 1996; 118: 1433–1440
- Schwarzacher S., Raberger G. L-NG-Nitro-Arginine Methyl Ester in the Anesthetized Rabbit: Venous Vasomotion and Plasma Levels. J. Vasc. Res. 1992; 29: 290–292
- Pentel P., Benowitz N. Efficacy and Mechanism of Action of Sodium Bicarbonate in the Treatment of Desipramine Toxicity in Rats. J. Pharmacol. Exp. Ther. 1984; 230: 12–19
- Brun G.J., Keyler D.E., Pond S.M., Pentel P.R. Reversal of Desipramine Toxicity in Rats Using Drug-specific Antibody Fab Fragments: Effects on Hypotension and Interaction with Sodium Bicarbonate. J. Pharmacol. Exp. Ther. 1992; 260: 1392–1399
- Wang Y.X., Poon C.I., Pang C.C.Y. Vascular Pharmacodynamics of NG-Nitro-l-Arginine Methyl Ester In Vitro and In Vivo. J. Pharmacol. Exp. Ther. 1993; 1091–1099
- Togashi K., Sakuma I., Yoshioka M., Kobayashi T., Yasuda H., Kitabatake A., Saito H., Gross S.S., Levi R. A Central Nervous System Action of Nitric Oxide in Blood Pressure Regulation. J. Pharmacol. Exp. Ther. 1992; 262: 343–347
- Toda N., Kitamura Y., Okamura T. Neural Mechanism of Hypertension by Nitric Oxide Synthase Inhibitor in Dogs. Hypertension 1993; 21: 3–8